Crystal structure of the human OX2 orexin receptor bound to the insomnia drug suvorexant

Jie Yin, Juan Carlos Mobarec, Peter Kolb, Daniel M. Rosenbaum

Research output: Contribution to journalArticle

132 Scopus citations

Abstract

The orexin (also known as hypocretin) G protein-coupled receptors (GPCRs) respond to orexin neuropeptides in the central nervous system to regulate sleep and other behavioural functions in humans. Defects in orexin signalling are responsible for the human diseases of narcolepsy and cataplexy; inhibition of orexin receptors is an effective therapy for insomnia. The human OX 2 receptor (OX 2 R) belongs to the β branch of the rhodopsin family of GPCRs, and can bind to diverse compounds including the native agonist peptides orexin-A and orexin-B and the potent therapeutic inhibitor suvorexant. Here, using lipid-mediated crystallization and protein engineering with a novel fusion chimaera, we solved the structure of the human OX 2 R bound to suvorexant at 2.5 Å resolution. The structure reveals how suvorexant adopts a π-stacked horseshoe-like conformation and binds to the receptor deep in the orthosteric pocket, stabilizing a network of extracellular salt bridges and blocking transmembrane helix motions necessary for activation. Computational docking suggests how other classes of synthetic antagonists may interact with the receptor at a similar position in an analogous π-stacked fashion. Elucidation of the molecular architecture of the human OX 2 R expands our understanding of peptidergic GPCR ligand recognition and will aid further efforts to modulate orexin signalling for therapeutic ends.

Original languageEnglish (US)
Pages (from-to)247-250
Number of pages4
JournalNature
Volume519
Issue number7542
DOIs
StatePublished - Mar 12 2015

ASJC Scopus subject areas

  • General

Fingerprint Dive into the research topics of 'Crystal structure of the human OX2 orexin receptor bound to the insomnia drug suvorexant'. Together they form a unique fingerprint.

  • Cite this